CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-09 | Mintz Paul Director | Option exercise | +50,000 | $0.40 | $20K | 117,385 |
| 2025-12-09 | Mintz Paul Director | Shares withheld for taxes | −9,091 | $2.20 | $20K | 108,294 |
| 2025-12-09 | Mintz Paul Director | Option exercise | +50,000 | $0.40 | $20K | 117,385 |
| 2025-12-09 | Mintz Paul Director | Shares withheld for taxes | −9,091 | $2.20 | $20K | 108,294 |
| 2025-11-28 | JORDEN DAVID EMERSON CEO/CFO | Sale | −200,000 | $1.50 | $300K | 1,946,755 |
| 2025-08-01 | WINZER C ERIC Director | Option exercise | +120,313 | $0.40 | $48K | 145,313 |
| 2025-08-01 | WINZER C ERIC Director | Shares withheld for taxes | −27,659 | $1.74 | $48K | 117,654 |
| 2025-08-01 | WINZER C ERIC Director | Option exercise | +120,313 | $0.40 | $48K | 145,313 |
| 2025-08-01 | WINZER C ERIC Director | Shares withheld for taxes | −27,659 | $1.74 | $48K | 117,654 |
| 2025-08-01 | Mintz Paul Director | Option exercise | +87,500 | $0.40 | $35K | 87,500 |
| 2025-08-01 | Mintz Paul Director | Shares withheld for taxes | −20,115 | $1.74 | $35K | 67,385 |
| 2025-08-01 | JORDEN DAVID EMERSON CEO/CFO | Option exercise | +100,000 | $0.40 | $40K | 2,075,358 |
| 2025-08-01 | JORDEN DAVID EMERSON CEO/CFO | Option exercise | +92,710 | $0.40 | $37K | 2,168,068 |
| 2025-08-01 | JORDEN DAVID EMERSON CEO/CFO | Shares withheld for taxes | −21,313 | $1.74 | $37K | 2,146,755 |
| 2025-07-31 | CLAUSEN PETER CSO/COO | Option exercise | +183,853 | $0.40 | $74K | 770,054 |
| 2025-07-30 | Pittman Scott M. Director | Grant or award | +3,946 | $1.50 | $6K | 5,400,000 |
| 2025-07-30 | SHEEDY CHARLES E 10% owner | Purchase | +133,333 | $1.50 | $200K | 11,570,833 |
| 2024-11-15 | Pittman Scott M. Director | Option exercise | +121,875 | $0.40 | $49K | 5,300,220 |
| 2024-11-15 | Pittman Scott M. Director | Option exercise | +62,500 | $0.40 | $25K | 5,362,720 |
| 2024-11-15 | Pittman Scott M. Director | Option exercise | +33,334 | $0.50 | $17K | 5,396,054 |
Page 3 of 17 · 326 trades